.hidden-seo { position: absolute; width: 1px; height: 1px; padding: 0; margin: -1px; overflow: hidden; clip: rect(0, 0, 0, 0); white-space: nowrap; border: 0; }

Omega-3 Algal EPA & Flaxseed Oil Softgel Blend for Heart Health

Omega-3 EPA Algal Oil & Flaxseed Softgel Solution

Algal EPA & Flaxseed Oil Softgel Blend is a functional omega-3 lipid formulation combining EPA-rich oil derived from the marine microalgae Nannochloropsis with plant-based flaxseed oil naturally rich in alpha-linolenic acid (ALA). This synergistic blend provides complementary omega-3 fatty acids designed to support cardiovascular health, lipid metabolism balance, and metabolic wellness.

Nannochloropsis microalgae are recognized as one of the primary natural producers of eicosapentaenoic acid (EPA), an essential omega-3 polyunsaturated fatty acid widely studied for its role in cardiovascular health. Through controlled photosynthetic cultivation, microalgae convert atmospheric CO₂ into valuable bioactive components such as EPA, polar lipids, polysaccharides, proteins, and peptides.

Unlike conventional marine oils derived from fish or krill, microalgae-based EPA originates directly from the base of the marine food chain, eliminating concerns related to food-chain accumulation of contaminants. The resulting algal oil naturally contains EPA without DHA, making it particularly suitable for targeted cardiovascular nutrition formulations.

When combined with flaxseed oil, which provides plant-derived omega-3 ALA, the formulation delivers a balanced lipid profile for modern functional nutrition products.

This EPA algal oil and flaxseed oil blend is commonly developed as softgel capsules for cardiovascular health supplements and can also be supplied as a bulk oil blend for further formulation. OEM and private-label manufacturing solutions are available for global nutraceutical brands and health product manufacturers.